World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
60
Citations
12782
World Ranking
11955
National Ranking
5131

Gary L. Schieven publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Gary L. Schieven sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 136 publications — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Gary L. Schieven D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Gary L. Schieven sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 60 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Gary L. Schieven is affiliated with Genesis Biotechnology Group in the United States. Their research primarily focuses on immunology and microbiology, with a notable number of publications in related fields such as medicine. The scientist's work spans several subfields, including immunology, infectious diseases, molecular biology, oncology, and emergency medical services.

The main topics covered in their research include:

  • Immune Response and Inflammation
  • Interferon and Immune Responses
  • Immune Cells in Cancer
  • Pediatric Health and Respiratory Diseases
  • Asthma and Respiratory Diseases
  • Viral Infections and Vectors
  • Viral Infections and Outbreaks Research

Gary L. Schieven has contributed to several research articles, including:

  • Discovery of Potent and Orally Bioavailable Small Molecule Antagonists of Toll-like Receptors 7/8/9 (TLR7/8/9), 2020, ACS Medicinal Chemistry Letters
  • Discovery of Non-Nucleotide Small-Molecule STING Agonists via Chemotype Hybridization, 2022, Journal of Medicinal Chemistry
  • Identification of 2-Pyridinylindole-Based Dual Antagonists of Toll-like Receptors 7 and 8 (TLR7/8), 2022, ACS Medicinal Chemistry Letters
  • STING Agonist VB-85247 Induces Durable Antitumor Immune Responses by Intravesical Administration in a Non-Muscle-Invasive Bladder Cancer, 2024, Cancer Research
  • Discovery of Novel TLR7 Agonists as Systemic Agent for Combination With aPD1 for Use in Immuno-oncology, 2024, ACS Medicinal Chemistry Letters

The most common publication venues for their work include:

  • ACS Medicinal Chemistry Letters
  • Cancer Research
  • Journal of Medicinal Chemistry
  • Annals of the Rheumatic Diseases

Gary L. Schieven has collaborated frequently with several researchers, including:

  • David Critton
  • Shailesh Dudhgaonkar
  • Shana Posy
  • Sanjeev Gangwar
  • Gregory D. Vite

Best Publications

  • Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays.

    Louis J. Lombardo;Francis Y. Lee;Ping Chen;Derek Norris

  • Positive selection for loss of tetracycline resistance.

    B R Bochner;H C Huang;G L Schieven;B N Ames

  • 2-aminothiazole as a novel kinase inhibitor template. Structure-activity relationship studies toward the discovery of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1- piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (dasatinib, BMS-354825) as a potent pan-Src kinase inhibitor.

    Jagabandhu Das;Ping Chen;Derek Norris;Ramesh Padmanabha

  • Inhibition of tyrosine phosphorylation prevents T-cell receptor-mediated signal transduction.

    Carl H. June;Mary C. Fletcher;Jeffrey A. Ledbetter;Gary L. Schieven

  • The biology of p38 kinase: a central role in inflammation.

    Gary L. Schieven

  • Reactive oxygen intermediates activate NF-kappa B in a tyrosine kinase- dependent mechanism and in combination with vanadate activate the p56lck and p59fyn tyrosine kinases in human lymphocytes

    Gary L. Schieven;Jean M. Kirihara;Dorothea E. Myers;Jeffrey A. Ledbetter

  • Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation.

    Andrew E. Schade;Gary L. Schieven;Robert Townsend;Anna M. Jankowska

  • Cross-linking of Fc gamma receptor I (Fc gamma RI) and receptor II (Fc gamma RII) on monocytic cells activates a signal transduction pathway common to both Fc receptors that involves the stimulation of p72 Syk protein tyrosine kinase.

    P A Kiener;B M Rankin;A L Burkhardt;G L Schieven

  • CD28 ligation in T-cell activation: evidence for two signal transduction pathways.

    Jeffrey A. Ledbetter;John B. Imboden;Gary L. Schieven;Laura S. Grosmaire

  • The role of class II molecules in human B cell activation. Association with phosphatidyl inositol turnover, protein tyrosine phosphorylation, and proliferation.

    Peter J L Lane;Fiona M. McConnell;Gary L. Schieven;Edward A. Clark

  • ZAP-70 tyrosine kinase, CD45, and T cell receptor involvement in UV- and H2O2-induced T cell signal transduction.

    Gary L. Schieven;Robert S. Mittler;Steven G. Nadler;Jean M. Kirihara

  • The role of tyrosine phosphorylation in signal transduction through surface Ig in human B cells. Inhibition of tyrosine phosphorylation prevents intracellular calcium release.

    Peter J L Lane;Jeffrey A. Ledbetter;Fiona M. Mcconnell;Kevin Draves

  • p72syk tyrosine kinase is activated by oxidizing conditions that induce lymphocyte tyrosine phosphorylation and Ca2+ signals.

    Gary L. Schieven;Jean M. Kirihara;Debra L. Burg;Robert L. Geahlen

  • Syk interacts with tyrosine-phosphorylated proteins in human platelets activated by collagen and cross-linking of the Fc gamma-IIA receptor.

    F. Yanaga;A. Poole;J. Asselin;R. Blake

  • Cloning and expression of the tumor-associated antigen L6.

    John S. Marken;Gary L. Schieven;Ingegerd Hellstrom;Karl Erik Hellstrom

  • Role of Oxidative Stress in the Action of Vanadium Phosphotyrosine Phosphatase Inhibitors REDOX INDEPENDENT ACTIVATION OF NF-κB

    Cecile M. Krejsa;Steven G. Nadler;James M. Esselstyn;Terrance J. Kavanagh

  • Collagen stimulates tyrosine phosphorylation of phospholipase C‐γ2 but not phospholipase C‐γ1 in human platelets

    Robert A. Blake;Gary L. Schieven;Steve P. Watson

  • Tyrosine phosphorylation is a mandatory proximal step in radiation-induced activation of the protein kinase C signaling pathway in human B-lymphocyte precursors

    Fatih M. Uckun;Gary L. Schieven;Lisa M. Tuel-Ahlgren;Ilker Dibirdik

  • Interaction of the Cytoplasmic Tail of CTLA-4 (CD152) with a Clathrin-Associated Protein Is Negatively Regulated by Tyrosine Phosphorylation

    Jeffrey D. Bradshaw;Pin Lu;Gina Leytze;Julie Rodgers

  • Stimulation of protein tyrosine phosphorylation, phosphoinositide turnover, and multiple previously unidentified serine/threonine-specific protein kinases by the Pan-B-cell receptor CD40/Bp50 at discrete developmental stages of human B-cell ontogeny.

    Fatih M. Uckun;Gary L. Schieven;Ilker Dibirdik;Mridula Chandan-Langlie

Frequent Co-Authors

Jeffrey A. Ledbetter
Jeffrey A. Ledbetter University of Washington
Alejandro Aruffo
Alejandro Aruffo Syngenta (United States)
Marilyn Parsons
Marilyn Parsons University of Washington
Edward A. Clark
Edward A. Clark University of Washington
Joseph B. Bolen
Joseph B. Bolen Takeda (Japan)
Peter S. Linsley
Peter S. Linsley Benaroya Research Institute
Paul J. Martin
Paul J. Martin Fred Hutchinson Cancer Research Center
Ingegerd Hellström
Ingegerd Hellström University of Washington
Karl Erik Hellström
Karl Erik Hellström University of Washington
Steve P. Watson
Steve P. Watson University of Birmingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Gary L. Schieven

Trending Scientists

Recently Published Articles